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Abstract
Background: The Cessation in Pregnancy Incentives Trial (CPIT), which offered financial incentives for smoking
cessation during pregnancy showed a clinically and statistically significant improvement in cessation. However, infant
birth weight was not seen to be affected. This study re-examines birth weight using an intuitive and a complier
average causal effects (CACE) method to uncover important information missed by intention-to-treat analysis.
Methods: CPIT offered financial incentives up to £400 to pregnant smokers to quit. With incentives, 68 women (23.1%)
were confirmed non-smokers at primary outcome, compared to 25 (8.7%) without incentives, a difference of 14.3%
(Fisher test, p < 0.0001). For this analysis, randomised groups were split into three theoretical sub-groups: independent
quitters - quit without incentives, hardened smokers - could not quit even with incentives and potential quitters -
required the addition of financial incentives to quit. Viewed in this way, the overall birth weight gain with incentives is
attributable only to potential quitters. We compared an intuitive approach to a CACE analysis.
Results: Mean birth weight of potential quitters in the incentives intervention group (who therefore quit) was 3338 g
compared with potential quitters in the control group (who did not quit) 3193 g. The difference attributable to incentives,
was 3338 – 3193 = 145 g (95% CI −617, +803). The mean difference in birth weight between the intervention and control
groups was 21 g, and the difference in the proportion who managed to quit was 14.3%. Since the intervention consisted
of the offer of incentives to quit smoking, the intervention was received by all women in the intervention group.
However, “compliance” was successfully quitting with incentives, and the CACE analysis yielded an identical result, causal
birth weight increase 21 g ÷ 0.143 = 145 g.
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Conclusions: Policy makers have great difficulty giving pregnant women money to stop smoking. This study indicates
that a small clinically insignificant improvement in average birth weight is likely to hide an important clinically significant
increase in infants born to pregnant smokers who want to stop but cannot achieve smoking cessation without the
addition of financial voucher incentives.
Trial Registration: ISRCTN Registry, ISRCTN87508788. Registered on 1 September 2011.
Keywords: Treatment effectiveness, Birth weight, Smoking cessation, Pregnancy
Background
Healthy birth weight is important for both early and
long-term infant and child health as well as adult health.
Healthcare costs are increased throughout life for low
birth-weight babies. Babies born smaller develop more
problems in the first month of life, requiring care in
level 3 and level 4 neonatal intensive care units [1].
Small babies are more likely to die suddenly and unex-
pectedly in the first year of life [2]. They will also be less
successful at attaining appropriate academic grades at
school [3]. Infants who are small for gestational age are
more likely to develop high blood pressure and other
cardiovascular problems in later life [4, 5]. Babies born
to smokers are more likely to develop obesity as they
grow up and will generally be of lower birth weight even
after adjusting for gestation [6].
Healthcare costs associated with lower birth weight are
substantial and are at least partially avoidable if women do
not smoke during pregnancy [7]. Smoking during preg-
nancy, as a risk factor on its own, will result in a baby
born 160 g smaller to women who continue to smoke up
to nine cigarettes per day and 230 g smaller to those who
continue to smoke more than nine cigarettes per day) [8].
Interventions to help women to reduce or stop smoking
during pregnancy, whilst of varying efficacy, have led to an
overall moderate but statistically significant increase of 41 g
in mean birth weight [9]. Financial incentive intervention
studies carried out by one research group in the USA re-
ported high efficacy (34.1% cessation) in the intervention
group offered incentives contingent on biochemically
validated cessation. This compared with 7.4% cessation in
those offered incentives not contingent on cessation. Mean
birth weight was 202 g greater in the intervention group
[10]. This difference was highly statistically and clinically
significant.
The Cessation in Pregnancy Incentives Trial (CPIT) [11]
(Additional files 1 and 2) was a large single-centre trial with
moderate to high efficacy, with a 23.5% quit rate in the
group offered financial incentives for biochemically vali-
dated cessation, and 8.6% in the control group not offered
incentives. This difference in validated cessation towards
the end of pregnancy was highly significant. However, mean
birth weight was only 21 g greater in the incentives group
and this result was not statistically significant (p = 0.67).
This paper looks again at birth weight data from the
CPIT and puts forward an alternative analysis. It aims to
show the real effect on birth weight in women who would
not quit without financial incentives but who manage to
quit when financial incentives are added to routine cessa-
tion services. This intuitive approach is compared with a
Complier Average Causal Effects (CACE) analysis.
Methods
The CPIT was a phase II single-centre efficacy trial that
offered up to £400 of financial incentives to self-reported
pregnant smokers to engage with smoking cessation
services and quit smoking near the end of pregnancy.
Enrolment of participants included women who were rep-
resentative of all self-reported pregnant smokers identified
routinely at maternity booking in the National Health Ser-
vice (NHS) Greater Glasgow and Clyde Health Board area
[12]. The primary outcome was cotinine-validated self-
report of smoking cessation collected between 34 and
38 weeks gestation corroborated by saliva (or urine) cotin-
ine estimation. Excluding participants who had multiple
births (n = 5), 607 women were randomised in the CPIT
(304 in the incentives, 303 in the control group). Of these,
the birth weight of their baby was not available for nine
women in the incentives group and 16 in the control
group, leaving 582 mother/baby pairs for analysis.
In the incentives group, 68 women (23.1%) were con-
firmed non-smokers at 34–38 weeks gestation compared
to 25 women (8.7%) in the control group, a difference of
14.3% (Fisher test, p < 0.0001). The mean birth weight of
women who stopped smoking was 3473 g, compared to
3065 g in women who continued to smoke, a difference
of 408 g (two-sample t test, p < 0.0001). Given these dif-
ferences, it might be expected that the difference in
mean birth weight between randomised groups would be
0.143 × 408 g, or 59 g. In fact, the difference in birth
weight between randomised groups was only 21 g (two-
sample t test, p = 0.67).
To examine why the CPIT intention-to-treat (ITT)
analysis, unlike other trials [10], showed no significant
increase in birth weight despite reporting highly signifi-
cant differences in both the quit rate in those offered in-
centives and those not [11] and the birth weight of
babies born to those who quit smoking and those who
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did not, we intuitively examined birth weights by group
(incentives, no incentives, quitters, non-quitters). We
compared our results with those of CACE analysis.
Statistical analyses
Statistical analyses were performed with R for Windows
v3.2.4 [13] and SAS for Windows v9.3 [14]. To obtain
the confidence interval for the difference in birth
weights, we used a bootstrapping approach; 10,000 repli-
cated datasets were drawn with replacement from the
original dataset, and for each replicate, estimates were
obtained for the mean birth weight for various sub-
groups of women, under the assumptions of receiving
the intervention or not. Mean values in each subgroup
and differences between groups are reported with 95%
bias-corrected and accelerated confidence intervals.
Results
Birth weight of babies by group allocation and primary
outcome (cotinine-validated self-report of smoking cessation
at 34–38 weeks gestation near the end of pregnancy)
Table 1 and Fig. 1 show the birth weights of babies born to
women in the trial, broken down by randomised group and
cotinine-validated smoking cessation near the end of preg-
nancy. As can be seen, babies of women in the incentives
group who continued to smoke had a birth weight 22 g less
than continuing smokers in the control group. Similarly,
women in the incentives group who managed to quit had
babies with a mean birth weight 154 g less than control
group women who stopped smoking. Whilst neither of
these differences was statistically significant, it is noticeable
in both scenarios that birth weights in the incentives group
were lower than in the control group. Nevertheless, since
more women in the incentives group were able to stop
smoking, the net effect was that babies born to women in
the incentives group were on average slightly bigger (21 g).
Intuitive approach to assess the effect of incentives
hidden by ITT analysis
Those women in the incentives group who continued to
smoke were doing so despite the offer of incentives to quit.
In that respect, they can be seen as a group of “hardened
smokers”, who could not be encouraged to quit with the
incentives on offer. It is not unreasonable to think that these
women may lead the least healthy lifestyles of those in the
trial. These are the women who had the smallest babies.
Similarly, those in the control group who managed to
quit, did so despite not being offered any additional in-
centive, beyond the health benefits of stopping smoking.
These women can be viewed as “independent quitters”,
i.e. the least entrenched in their habit, and most able to
quit. It may well be the case that these women adopted
other healthy lifestyle choices during their pregnancies.
These women had the largest babies.
Following this logic, the control group women who
continued to smoke can be seen to be made up of two
subgroups: the hardened smokers as aforementioned,
plus women who might have been able to quit, if they
had been offered incentives. By the same token, women
in the incentives group who quit smoking likely includes
some independent quitters, plus women who managed
to stop smoking as a result of being offered incentives
(and who might not have quit had they not been offered
any incentives).
Therefore, both the control group smokers, and the in-
centives group quitters, include women in a third subgroup
who, when offered incentives are able to stop smoking, but
without incentives, continue to smoke. This group could be
viewed as “potential quitters”, who probably tend to make
(or are more able to make) healthier lifestyle choices than
the hardened smokers, but not to the same extent as the
independent quitters.
If we define the probabilities of being a hardened
smoker, an independent quitter or a potential quitter as
PHS, PIQ and PPQ, respectively, then from the proportion
of the incentives group who continued to smoke, we can
estimate PHS as 0.769 (76.9%); from the proportion of
the control group who managed to quit, we can estimate
PIQ as 0.087 (8.7%). Therefore, we can estimate the pro-
portion of potential quitters, PPQ, as 1 − 0.769 − 0.087 =
0.143 (14.3%). This is exactly the same percentage as the
difference between the incentives group and the control
group who managed to quit.
The mean birth weight for a baby of a hardened smoker,
WHS, can be estimated from the mean birth weight of ba-
bies born to women in the incentives group who continued
to smoke, i.e. 3053 g. The mean birth weight for a baby of
an independent quitter, WIQ, can be estimated using the
mean birth weight of babies born to women in the control
group, who managed to quit, i.e. 3586 g.
What we are interested in is the mean birth weight of
babies born to potential quitters who are either offered
incentives and manage to quit (WPQQ), or who are not
offered incentives and therefore continue to smoke (WPQS).
The difference between these two values, WPQQ −WPQS,
Table 1 Birthweight (g) by randomised group and smoking
status at end of pregnancy (primary outcome)
Primary outcome All
Smoker Non-smoker
Randomised
group
Control N = 262
3075 (569)
N = 25
3586 (566)
N = 287
3120 (586)
Incentives N = 227
3053 (588)
N = 68
3432 (527)
N = 295
3141 (595)
All N = 489
3065 (577)
N = 93
3473 (539)
N = 582
3130 (590)
Results are presented as number of observations (N) and mean (standard
deviation); 25 birth weights were missing, as they were not available from
routinely collected data
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can be seen as the gain in birth weight attributable to the
offer of incentives, for babies born to women who are po-
tential quitters. However, we do not have any direct means
of estimating these two mean birth weights.
The mean birth weight of babies born to women in the
incentives group who managed to quit (W1) can be thought
of as a weighted mean of the birth weight of babies born to
the independent quitters (WIQ) and the potential quitters
who were able to quit (WPQQ) within this group:
W1 ¼ PIQ WIQ þ PPQ WPQQ
   PIQ þ PPQ
 
;
so that
WPQQ ¼ W1  PIQ þ PPQ
 
‐ PIQ WIQ
   PPQ ¼ 3338g:
Similarly, the mean birth weight of babies born to
women in the control group who continued to smoke
(W0) can be seen as a weighted mean of the birth weight
of babies born to the hardened smokers (WHS) and the
potential quitters who were not able to quit (WPQS):
W0 ¼ PHS WHS þ PPQ WPQS
   PHS þ PPQ
 
;
so that
WPQS ¼ W0  PHS þ PPQ
 
‐ PHS WHS
   PPQ ¼ 3193g:
So, the difference in mean birth weight attributable to
the offer of incentives, amongst those women with the po-
tential to benefit, can be estimated as 3338 − 3193 = 145 g.
In order to assess the statistical significance of this differ-
ence, we applied a bootstrapping procedure, with 10,000
replicated datasets, giving a 95% confidence interval for this
difference of −617 g to +803 g. This confidence interval is
wide, and includes zero, so there is no statistical evidence of
an increase in birth weight attributable to the intervention.
The bootstrapping procedure also provided confidence
intervals for the estimates of mean birth weight for each
subgroup separately: the hardened smokers, independent
quitters, and the potential quitters with incentives (who
continued to smoke) or with incentives (who were able
to quit), as shown in Fig. 2. There is huge uncertainty in
the estimated mean birth weight of the potential quitters
who were not offered incentives. Nevertheless, the trend
in estimated mean birth weights from the hardened
smokers to the independent quitters is striking, and
illustrates that the potential quitters are an intermediate
group, with average birth weights between those of the
two extreme groups.
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Complier average causal effect (CACE) method to uncover
an incentives effect hidden by ITT analysis
In the simplest formulation of a CACE analysis, partici-
pants are classified as compliers or non-compliers with
the intervention. For a continuous outcome, the mean
value in the intervention group (μ1) and the control
group (μ0), are viewed as weighted means of the mean
values in these two subgroups of participants:
μ0 ¼ πcμc0 þ πnμn; and
μ1 ¼ πcμc1 þ πnμn
where πc and πn are the proportions of compliant and
non-compliant individuals in the population, μn is the mean
response for non-compliant individuals (which is the same
in the intervention and control groups), and μc0 and μc1 are
the mean outcomes for compliant individuals, which
depends on whether the individual is randomised to the
intervention or control group (and therefore receives the
intervention or not). Under this formulation, the CACE
can be estimated as:
μc1‐ μc0 ¼ μ1‐ μ0ð Þ  πc
However, in this situation, all women in the interven-
tion group were offered incentives to stop smoking, i.e.
all intervention group women “received” the interven-
tion, and were therefore compliant with it. On the face
of it, a CACE analysis in this situation is not applicable.
The above description of the CACE analysis is actually a
simplification of a more general formulation. In general,
the population can be divided into four groups: compliers
(who receive the intervention if it is offered), non-
compliers (who do not receive the intervention when it is
offered), “always takers” (who receive the intervention
whether it is offered or not), and “defiers” (who receive
the intervention when it is not offered, and do not receive
it when it is offered). The simple formulation described
above is based on the (not unreasonable) assumption that
in a randomised trial, there is no opportunity to be an
always taker or a defier (i.e. πa and πd = 0). However, the
general CACE formulation begins to make sense when we
see that it is an instrumental variable analysis: in general,
the CACE analysis treats randomisation to the interven-
tion as an instrumental variable, which can only affect the
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outcome via the mediator (receiving the intervention).
The language used in the CACE formulation maybe does
not fit, but the principles do: in our data, we assume that
the instrumental variable of randomisation to receive the
offer of incentives to stop smoking can only affect birth
weight via the mediator of quitting smoking. “Compliers”
are now seen as women who quit when randomised to be
offered incentives, but continue to smoke when rando-
mised to not receive the offer of incentives, “non-com-
pliers” are those who continue to smoke whether
randomised to be offered incentives or not, and “always
takers” are women who quit regardless of which group
they are randomised into. We can assume that there are
no “defiers” (i.e. women who quit only when given no in-
centive, but refuse to quit if offered incentives).
The mean outcome in the two groups can now be seen as:
μ0 ¼ πc μc0 þ πn μn þ πa μa and
μ1 ¼ πc μc1 þ πn μn þ πa μa
We assume that the average outcome for those who
never quit or always quit are the same regardless of the ran-
domisation. So, as in the simple setting, we can estimate
the difference in outcome between compliers in the two
randomised groups is:
μc1 ‐ μc0 ¼ μ1 ‐ μ0ð Þ  πc
Therefore, the CACE analysis simplifies to the average
birth weight of babies of intervention participants
(3141 g) minus the average birth weight of control partici-
pants (3120 g) divided by the proportion of women who
stop smoking only when offered an incentive. Since the
total proportion who quit smoking in the incentives group
is πa + πc, and in the no incentives group is πa, we can es-
timate πc as the difference in the proportion who quit
smoking between the two randomised groups (0.143), i.e.:
μc1‐ μc0 ¼ 3141g – 3120gð Þ  0:143 ¼ 145g
This is exactly the same value as was obtained by the
intuitive approach described earlier. In fact, the two ap-
proaches are the same; the group we identified as “inde-
pendent quitters” are the “always takers” of CACE
notation, the “hardened smokers” are “non-compliers”,
and “potential quitters” are “compliers”.
Discussion
The estimated increase in birth weight caused by the
offer of incentives in the CPIT trial was 21 g overall, but
for the subgroup of women who quit as a result of the
offer of incentives, and would not have been able to do
so without the offer, it was 145 g. Throughout, we have
viewed this as the causal effect of the intervention,
within the subgroup who are susceptible to (comply
with) it, but the value of 145 g can equally be seen as
the causal effect of stopping smoking on birth weight,
within this subgroup of women for whom the offer of in-
centives is sufficient to help them to quit. This is in line
with birth weight differences associated with smoking
cessation recorded by other researchers - 160 grams for
light smoking (1–9 cigarettes per day) and 230 grams for
heavy smoking (>9 cigarettes per day) [8].
To try to understand this analysis, Fig. 1 gives the raw
data. Comparison of those who continued to smoke
shows that those in the incentives group had babies with
a slightly lower birth weight on average compared with
those who continue to smoke in the control group. This
indicates that the other variables related to birth weight
(that make up the 450 g difference in birth weight be-
tween continuing smokers and quitters) were more
prevalent in those who were unable to quit in the inter-
vention group. Comparison of those who quit shows
that those in the control group were all independent
quitters who had other characteristics associated with
higher birth weight, whereas some in the intervention
group are potential quitters who are likely to have other
characteristics that reduce birth weight. Overall com-
parison of those who continued to smoke and those who
quit from both groups shows a 450 g difference in birth
weight. Our analysis indicates that only 145 g of the
450 g difference in birth weight between continuing
smokers and quitters is due to smoking cessation that
takes place after maternity booking. The last comparison
shows that overall the offer of incentives to pregnant
smokers only increases birth weight by 21 g on average
compared with those not offered incentives.
Figure 2 illustrates the birth weight of babies born to
hardened smokers (those who continued to smoke even
when offered incentives to quit - calculated from the
intervention group) was 3050 g and the birth weight of
babies born to those who independently quit without
the offer of incentives (those who quit without incentives
- calculated from the control group quitters) was 3600 g.
Potential quitters from each group are calculated by re-
moving the above groups’ numbers and weights from
the overall birth weight of babies in each group and then
dividing the overall remaining birth weight of babies in
each group by the number of potential quitters (14.3%)
for each group (those who quit because of the offer of
incentive payments). These calculated values are for po-
tential quitters in each group (in the incentives group
women who quit because they were offered incentive
payments, in the control group those who did not quit
because they were not offered incentive payments). The
difference between these two calculated values is 145 g
and represents the difference in birth weight caused by
the incentive payments offered to quit smoking. The
other differences between women are responsible for the
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further 400 g difference in birth weight between babies
born to hardened smokers and independent quitters.
These differences may include both characteristics re-
lated to smoking such as number of cigarettes smoked
per day and partner smoking and other characteristics
not directly related to smoking such as maternal
deprivation score (as illustrated in Additional file 3:
Table S2 reference [11]).
We initially thought that a CACE analysis was not
relevant, since the notion of compliance and non-
compliance (e.g. taking or not taking tablets in a drug
trial) was not applicable in a trial of the offer of incen-
tives, which was received by all women randomised to
receive it (and none of those randomised to not receive
it). We therefore pursued an intuitive analysis, estimat-
ing the mean birth weight of two subgroups of women
unaffected by the intervention (hardened smokers and
independent quitters), leading to estimates of the mean
birth weight for a third group of potential quitters, with
and without the offer, and therefore to the estimate of
the causal effect of the intervention for these women.
We found, however, that the CACE approach could be
used, even though the terminology was slightly incon-
gruous in this setting. This gave us some reassurance
that our intuitive approach was valid. Also, whilst the
CACE approach gave an estimate of the causal effect of
the intervention, the intuitive approach provided us with
estimates of the mean birth weight of each subgroup
separately, and for the potential quitters, of the mean
birth weight with and without the offer of incentives.
We feel that this has given us a greater understanding of
the characteristics of these subgroups and the impact of
the intervention.
It should be noted that: (1) the trial aimed to examine
the effect of the offer of financial incentives in addition
to routine smoking cessation service support to engage
with smoking cessation services and/or quit smoking
during pregnancy. This means that examining the effect
on birth weight only in potential quitters (those who can
quit only with the offer of incentives) may be of limited
public health importance; (2) neither of these estimates
is anywhere near statistically significant (95% CI −615 g
to +803 g). In order for a trial to have 80% power to de-
tect an effect on birth weight, if we take 100 g as a clin-
ically important effect (in those who manage to quit as a
result of the intervention), then we estimate a study of
27,637 participants (per group, or 55,274 in total) would
be required. This assumes that 14.3% of women stop
smoking as a result of the offer of incentives, so the
mean difference in birth weight between randomised
groups will be 14.3 g. This is clearly not feasible. In
order to improve the power of a trial to detect an effect
on birth weight, then the intervention itself must be im-
proved to increase the impact on quit rates (e.g. by
optimising the package of incentives on offer), the inter-
vention must be targeted at those most likely to be a po-
tential quitter (which would likely be seen as unethical),
or the analyses outlined in this report must be improved
to estimate the causal effect of the intervention on birth
weight.
Since completing the analyses described in this report,
we have become aware of two avenues for further work.
Our analyses are the same as a very simple two-stage
least squares analysis [15]; we confirmed this using the
AER package within R [16] and obtained the same esti-
mate of the birth weight difference due to the interven-
tion, 145.2 g, with a 95% CI of −511.4 g to 801.7 g,
which is not dissimilar to our CI, derived by bootstrap-
ping. Another way the data could be analysed is as a
mixture model within a Bayesian framework [17]. Each
of these methods could be used to develop more com-
plex models incorporating covariate effects, potentially
reducing the uncertainty around the estimate of the ef-
fect of the intervention on birth weight. It might there-
fore be possible to design a study powered to detect
such effects, without the need for tens of thousands of
randomised participants.
Nevertheless, whilst an overall 21-g average improve-
ment in birth weight may appear trivial, our analyses
show that for individual mothers who benefit from the
intervention and manage to give up smoking during
pregnancy as a result, there may be a substantial in-
crease in the birth weight of their infant.
Limitations of the study
This study uses secondary outcome data from a rando-
mised controlled trial. It adds to evidence from trial data
on smoking cessation in pregnancy in relation to im-
provements in birth weight [9]. Our analysis demon-
strates how the CACE framework can be used to
estimate the causal impact of an intervention to improve
smoking quit rates, on a “downstream” outcome, birth
weight. By approaching the same problem from an intui-
tive angle, we also derived estimates of mean birth
weight in two subgroups of women who are not directly
observed. We have not adjusted our analyses for any
baseline characteristics; if this is possible, it may provide
more precise estimates of the causal effect of the inter-
vention on birth weight, and ultimately make possible a
large-scale trial, powered to detect such effects. We shall
continue to investigate this possibility.
Implications for practice
This analysis supports the offer of financial incentives to
help pregnant smokers to stop smoking during preg-
nancy in order to improve outcomes for infants, by in-
creasing their birth weight.
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Conclusion
In the current financial climate, advocating the offer of
financial incentives to pregnant smokers to engage with
smoking cessation services and or quit smoking is
difficult. Demonstrating that the clinically insignificant
improvement in average birth weight of 21 g hides a
clinically significant estimated increase in birth weight of
145 g, amongst those women who manage to give up
smoking as a result of the intervention, helps to justify
the offer of incentives for smoking cessation as a reason-
able intervention to consider.
Additional files
Additional file 1: Flow diagram of the CPIT II [11]. (DOCX 2446 kb)
Additional file 2: Consort checklist submitted with the manuscript for
the CPIT II [11]. (DOC 219 kb)
Additional file 3: Table S2. from the CPIT [11] (DOCX 13 kb)
Abbreviations
CACE: complier average causal effects; CPIT: Cessation in Pregnancy
Incentives Trial; NHS: National Health Service
Acknowledgements
We would like to acknowledge the help and support of NHS Greater
Glasgow and Clyde R&D department, in particular Dr Roma Armstrong and
Brenda Colvin, without whose help this trial would not have been possible.
Funding
This study was funded by a grant from the Chief Scientist Office Scottish
Government CZH/4/594, Glasgow Centre for Population Health, NHS Greater
Glasgow and Clyde Endowments, the Royal Samaritan Endowment Fund
and Glasgow Children’s Hospital Charity.
Availability of data and materials
Raw data from this trial may be made available on request by Professor Tappin.
Authors’ contributions
AM supervised the initial trial analysis, re-analysed the data for this paper and
drafted the text. CH analysed the data for this paper. LB was involved in
designing the study and drafting the article. LS was involved in data
acquisition and cleaning, designing the study, and drafting and proofreading
the article. LS ran the trial on a day-to-day basis and assisted with study
design and data acquisition and cleaning for analyses, and was involved in
writing and editing this paper. DT conceived the study and was involved in
designing the study, and drafting and proofreading the article. DT
coordinated and managed the overall running of the trial, fully supervised
this project and was closely involved in data analyses and the paper writing.
All authors read and approved the final manuscript.
Authors’ information
1. Alex McConnachie is Deputy Director of the Robertson Centre for
Biostatistics, Glasgow University.
2. Caroline Haig is a Post Doctoral Statistician in the Robertson Centre for
Biostatistics, Glasgow University.
3. Linda Bauld (Co-Principal Investigator) is Professor of Health Policy,
University of Stirling and UK Centre for Tobacco and Alcohol Studies, and
has extensive experience of quantitative work related to smoking cessation.
4. Lesley Sinclair (Trial Manager) has experience of data management and
the management of clinical trials.
5. David Tappin (Co-Principal Investigator) is Professor of Clinical Trials for
Children based at Glasgow University.
Ethics approval and consent to participate
The Cessation in Pregnancy Incentives Trial (CPIT) was approved by the NHS
West of Scotland Research Ethics Committee 2 (11/AL/0204). All participants
gave informed consent to take part in this trial.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Robertson Centre, Level 11, Boyd Orr Building, University of Glasgow,
Glasgow G12 8QQ, UK. 2Institute for Social Marketing, Centre for Tobacco
and Alcohol Studies, Faculty of Health Sciences & Sport, University of Stirling,
Stirling FK9 4LA, UK. 3Section of Child Health, School of Medicine, Glasgow
University, Scottish Cot Death Trust, 5th floor, West Glasgow Ambulatory
Care Hospital, Yorkhill, Glasgow G3 8SJ, UK.
Received: 6 September 2016 Accepted: 19 June 2017
References
1. Oster G, Delea TE, Colditz GA. Maternal smoking during pregnancy and
expenditures on neonatal health care. Am J Prev Med. 1988;4(4):216–9.
2. Smith GC, White IR. Predicting the risk for sudden infant death syndrome
from obstetric characteristics: a retrospective cohort study of 505,011 live
births. Pediatrics. 2006;117(1):60–6.
3. Hollowman HA, Scott KG. Influence of birth weight on educational
outcomes at age 9: the Miami Site of Infant Health and Development
Program. J Dev Behav Pediatr. 1998;19(6):404–10.
4. Valdez R, Athens MA, Thompson GH, Bradshaw BS, Stern MP. Birthweight
and adult health outcomes in a bi-ethnic population in the USA.
Diabetologia. 1994;37:624–31.
5. Roberts E, Wood P. Birth weight and adult health in historical perspective:
evidence from a New Zealand cohort, 1907–1922. Soc Sci Med. 2014;107:
154–61.
6. Durmus B, Kruithof CJ, Gillman MH, Willemsen SP, Hofman A, Raat H, Eilers
PHC, Steegers EAP, Jaddoe VWV. Parental smoking during pregnancy, early
growth, and risk of obesity in preschool children: the Generation R Study.
Am J Clin Nutr. 2011;94(1):164–71.
7. Mistry H, Dowie R, Franklin RC, Jani BR. Costs of neonatal care for low-
birthweight babies in English hospitals. Acta Paediatr. 2009;98(7):1123–9.
8. Juárez SP, Merlo J. Revisiting the effect of maternal smoking during
pregnancy on offspring birthweight: a quasi-experimental sibling analysis in
Sweden. PLoS One. 2013;8(4), e61734.
9 Chamberlain C, O'Mara-Eves A, Porter J, Coleman T, Perlen SM, Thomas J,
McKenzie JE. Psychosocial interventions for supporting women to stop
smoking in pregnancy. Cochrane Database Syst Rev. 2017;(Issue 2):
CD001055. doi:10.1002/14651858.CD001055.pub5.
10 Higgins ST, Bernstein IR, Washio Y, Heil SH, Badger GJ, Skelly JM, Higgins
TM, Solomon LJ. Effects of smoking cessation with voucher-based
contingency management on birth outcomes. Addiction. 2010;105:2023–30.
11 Tappin D, Bauld L, Purves D, Boyd K, Sinclair L, MacAskill S, McKell J, Friel B,
McConnachie A, De Caestecker L, Tannahill C, Radley A, Coleman T.
Financial incentives for smoking cessation in pregnancy: Randomised
controlled trial. BMJ. 2015;350:h134.
12 Bessing B, Bauld L, Sinclair L, Mackay DF, Spence W, Tappin DM.
Representativeness of the participants in the smoking Cessation in
Pregnancy Incentives Trial (CPIT): a cross-sectional study. Trials. 2016;17(1):
426. doi:10.1186/s13063-016-1552-5.
13 R Core Team. R: a language and environment for statistical computing. Vienna:
R Foundation for Statistical Computing; 2016. https://www.R-project.org/.
14 SAS 9.3 (SAS Institute, Cary NC)
15 Angrist JD, Imbens GW. Two-stage least squares estimation of average
causal effects in models with variable treatment intensity. J Am Stat Assoc.
1995;90:431–42.
McConnachie et al. Trials  (2017) 18:337 Page 8 of 9
16 Kleiber C, Zeileis A. Applied econometrics with R. New York: Springer-Verlag;
2008. ISBN 978-0-387-77316-2. https://CRAN.R-project.org/package=AER.
17 Hamilton B. Estimating treatment effects in randomized clinical trials with
non-compliance: the impact of maternal smoking on birthweight. Health
Econ. 2001;10:399-410 . doi:10.1002/hec.629.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
McConnachie et al. Trials  (2017) 18:337 Page 9 of 9
